Rebalancing cortical neuronal hyperactivity as a new treatment strategy in neuroinflammation

B09

In the previous funding period we discovered a maladaptive cortical network dysregulation linked with anxiety behavior as a pathological mechanism in murine neuroinflammation contributing to initiation of neurodegeneration. We now aim at (1) dissecting the causal relation between brainstem pathology and cortical maladaptive hyperactivity, (2) unravelling the relation of local network dysregulation to brain-wide networks, and (3) pharmacologically modulating cortical hyperexcitability and translating our findings to MS patients. These research questions will be investigated:

    1. Does the modulation of AMPA receptors have an effect in neuroinflammatory disorders?
    2. Does the reversal of anxiety symptoms prevent neurodegeneration?
    3. What’s the relation between local nework dysregulation in relapsing-remitting MS with brain-wide networks?
    4. Is there a causal relation between brainstem pathology and cortical maladaptive hyperactivity?

 

 

 

 

 

Principal Investigators:

Dr. med. Erik Ellwardt
Klinik für Neurologie
Mainz
erik.ellwardt@unimedizin-mainz.de

Prof. Dr. rer. nat. Albrecht Stroh
Institut für Mikroskopische Anatomie und Neurobiologie
Mainz
albrecht.stroh@unimedizin-mainz.de

News

Mon, 20/09/2021
Register now: 1st Symposium inflammation and imaging
When?: from November 2nd to November 4th 2021 Where?: Schloss (seat of the University Administration) Muenster Organizers: Co-operative Research Centres 1009, 1450, Transregio 128, and Clinical Research Unit 342 – together with Interdisciplinary Centre of Clinical Research (IZKF) and Excellence Cluster Cells in Motion (CiM) Registration is open now! More information: here...more
Mon, 09/08/2021
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity
A close interaction between gut immune responses and distant organ-specific autoimmunity including the CNS in multiple sclerosis has been established in recent years. This so-called gut-CNS axis can be shaped by dietary factors, either directly or via indirect modulation of the gut microbiome and its metabolites. Here, SFB 128 PI Luisa Klotz and colleagues report […]...more
Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more